MK
Manoj Kumar Tibrewal
About Manoj Kumar Tibrewal
Data last updated:
Manoj Kumar Tibrewal has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Vimal Febrics Manufacturers Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vimal Febrics Manufacturers Private Limited at ₹0.21 Cr (FY 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vimal Febrics Manufacturers Private Limited U17291BR2009PTC014450 | Director | 24 Apr 2009 | 2009 | ₹0.21 Cr (FY 2017) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manoj Kumar Tibrewal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manoj Kumar Tibrewal
Manoj Kumar Tibrewal has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Vimal Febrics Manufacturers Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vimal Febrics Manufacturers Private Limited at ₹0.21 Cr (FY 2017).
Manoj Kumar Tibrewal is associated with 1 company as Director, including Vimal Febrics Manufacturers Private Limited (₹0.21 Cr).
Manoj Kumar Tibrewal has expertise in General Business.
Manoj Kumar Tibrewal has 17 years in corporate governance.
By reported revenue, the largest current company of Manoj Kumar Tibrewal is Vimal Febrics Manufacturers Private Limited, with revenue of ₹0.21 Cr (FY 2017).
Manoj Kumar Tibrewal currently holds positions at 1 company: Vimal Febrics Manufacturers Private Limited (₹0.21 Cr).